Rituximab maintenance in follicular lymphoma: PRIMA

The Lancet

Volumn 377, Issue 9759, 2011, Pages 4-6

  Friedberg, Jonathan W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; DRUG WITHDRAWAL; FOLLICULAR LYMPHOMA; HUMAN; MAINTENANCE THERAPY; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 78650842699     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)62272-6     Document Type: Note

References (11)

1. RI Fisher, M LeBlanc, OW Press, DG Maloney, JM Unger, TP Miller New treatment options have changed the survival of patients with follicular lymphoma J Clin Oncol 23 2005 8447 8452
2. WT Swenson, JE Wooldridge, CF Lynch, VL Forman-Hoffman, E Chrischilles, BK Link Improved survival of follicular lymphoma patients in the United States J Clin Oncol 23 2005 5019 5026
3. R Marcus, K Imrie, A Belch CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma Blood 105 2005 1417 1423
4. W Hiddemann, M Kneba, M Dreyling Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group Blood 106 2005 3725 3732
5. JW Friedberg Unique toxicities and resistance mechanisms associated with monoclonal antibody therapy Hematol Am Soc Hematol Educ Program 1 2005 329 334
6. G Martinelli, SF Schmitz, U Utiger Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98 J Clin Oncol 28 2010 4480 4484
7. H Hochster, E Weller, RD Gascoyne Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study J Clin Oncol 27 2009 1607 1614
8. JW Friedberg, MD Taylor, JR Cerhan Follicular lymphoma in the United States: first report of the national LymphoCare study J Clin Oncol 27 2009 1202 1208
9. G Salles, JF Seymour, F Offner Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Lancet 2010 10.1016/S0140-6736(10)62175-7 published online Dec 21.
10. JH Anolik, JW Friedberg, B Zheng B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny Clin Immunol 122 2007 139 145
11. BS Kahl Eastern Cooperative Oncology Group 4402: Rituximab Extended Schedule or Retreatment Trial (RESORT) Clin Lymphoma Myeloma 6 2006 423 426